These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

129 related items for PubMed ID: 15351393

  • 1. Synthesis and biological activity of N-terminal lipidated and/or fluorescently labeled conjugates of astressin as corticotropin releasing factor antagonists.
    Rijkers DT, den Hartog JA, Liskamp RM.
    Bioorg Med Chem; 2004 Oct 01; 12(19):5099-106. PubMed ID: 15351393
    [Abstract] [Full Text] [Related]

  • 2. An optimized solid phase synthesis strategy--including on-resin lactamization--of astressin, its retro-, inverso-, and retro-inverso isomers as corticotropin releasing factor antagonists.
    Rijkers DT, den Hartog JA, Liskamp RM.
    Biopolymers; 2002 Feb 01; 63(2):141-9. PubMed ID: 11787002
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Constrained corticotropin releasing factor antagonists (astressin analogues) with long duration of action in the rat.
    Rivier JE, Kirby DA, Lahrichi SL, Corrigan A, Vale WW, Rivier CL.
    J Med Chem; 1999 Aug 12; 42(16):3175-82. PubMed ID: 10447963
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Structural requirements for peptidic antagonists of the corticotropin-releasing factor receptor (CRFR): development of CRFR2beta-selective antisauvagine-30.
    Rühmann A, Bonk I, Lin CR, Rosenfeld MG, Spiess J.
    Proc Natl Acad Sci U S A; 1998 Dec 22; 95(26):15264-9. PubMed ID: 9860957
    [Abstract] [Full Text] [Related]

  • 8. New class of corticotropin-releasing factor (CRF) antagonists: small peptides having high binding affinity for CRF receptor.
    Yamada Y, Mizutani K, Mizusawa Y, Hantani Y, Tanaka M, Tanaka Y, Tomimoto M, Sugawara M, Imai N, Yamada H, Okajima N, Haruta J.
    J Med Chem; 2004 Feb 26; 47(5):1075-8. PubMed ID: 14971886
    [Abstract] [Full Text] [Related]

  • 9. Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats.
    Martínez V, Rivier J, Taché Y.
    J Pharmacol Exp Ther; 1999 Aug 26; 290(2):629-34. PubMed ID: 10411571
    [Abstract] [Full Text] [Related]

  • 10. Binding differences of human and amphibian corticotropin-releasing factor type 1 (CRF(1)) receptors: identification of amino acids mediating high-affinity astressin binding and functional antagonism.
    Dautzenberg FM, Wille S.
    Regul Pept; 2004 May 15; 118(3):165-73. PubMed ID: 15003833
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Different binding modes of amphibian and human corticotropin-releasing factor type 1 and type 2 receptors: evidence for evolutionary differences.
    Dautzenberg FM, Py-Lang G, Higelin J, Fischer C, Wright MB, Huber G.
    J Pharmacol Exp Ther; 2001 Jan 15; 296(1):113-20. PubMed ID: 11123370
    [Abstract] [Full Text] [Related]

  • 13. Astressin-amide and astressin-acid are structurally different in dimethylsulfoxide.
    Grace CR, Cervini L, Gulyas J, Rivier J, Riek R.
    Biopolymers; 2001 Jan 15; 87(2-3):196-205. PubMed ID: 17657708
    [Abstract] [Full Text] [Related]

  • 14. Potent and long-acting corticotropin releasing factor (CRF) receptor 2 selective peptide competitive antagonists.
    Rivier J, Gulyas J, Kirby D, Low W, Perrin MH, Kunitake K, DiGruccio M, Vaughan J, Reubi JC, Waser B, Koerber SC, Martinez V, Wang L, Taché Y, Vale W.
    J Med Chem; 2002 Oct 10; 45(21):4737-47. PubMed ID: 12361401
    [Abstract] [Full Text] [Related]

  • 15. Restraint stress stimulates colonic motility via central corticotropin-releasing factor and peripheral 5-HT3 receptors in conscious rats.
    Nakade Y, Fukuda H, Iwa M, Tsukamoto K, Yanagi H, Yamamura T, Mantyh C, Pappas TN, Takahashi T.
    Am J Physiol Gastrointest Liver Physiol; 2007 Apr 10; 292(4):G1037-44. PubMed ID: 17158256
    [Abstract] [Full Text] [Related]

  • 16. The role of corticotropin releasing factor and its antagonist, astressin, on micturition in the rat.
    Klausner AP, Streng T, Na YG, Raju J, Batts TW, Tuttle JB, Andersson KE, Steers WD.
    Auton Neurosci; 2005 Dec 30; 123(1-2):26-35. PubMed ID: 16256445
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Constrained corticotropin-releasing factor antagonists with i-(i + 3) Glu-Lys bridges.
    Miranda A, Lahrichi SL, Gulyas J, Koerber SC, Craig AG, Corrigan A, Rivier C, Vale W, Rivier J.
    J Med Chem; 1997 Oct 24; 40(22):3651-8. PubMed ID: 9357532
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Pharmacological and chemical properties of astressin, antisauvagine-30 and alpha-helCRF: significance for behavioral experiments.
    Brauns O, Liepold T, Radulovic J, Spiess J.
    Neuropharmacology; 2001 Sep 24; 41(4):507-16. PubMed ID: 11543771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.